Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research.
September 19, 2023 03:00 ET
|
Olink Proteomics AB
Uppsala, Sweden, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research. ...
Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs
September 12, 2023 11:00 ET
|
Olink Proteomics AB
Uppsala, Sweden, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Eurofins Genomics adopts Olink® technology to advance proteomics research and accelerate precision medicine programs UPPSALA, Sweden, 12th...
Announcing Olink® Explore HT – A New Era in Proteomics
July 12, 2023 09:00 ET
|
Olink Proteomics AB
UPPSALA, Sweden, July 12, 2023 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink® Explore HT, a transformational solution for high-throughput...